feed,title,long_url,short_url
SeekingAlpha,Syndax's revumenib granted FDA orphan drug designation for leukemia,https://seekingalpha.com/news/4132433,
SeekingAlpha,Alcon: Trading At An Undeserved Premium Valuation,https://seekingalpha.com/article/4709164,
SeekingAlpha,On Holding: Too Expensive With Slower Growth Ahead,https://seekingalpha.com/article/4709162,
